Kojima Kensuke, Kaneda Kinuyo, Yasukawa Masaki, Tanaka Kazuo, Inoue Takeshi, Yamashita Takuya, Dansako Hiromichi, Sakugawa Sumie Takase, Kozuka Teruhiko, Hara Masamichi, Tanimoto Mitsune
Department of Medicine II, Okayama University Medical School, Okayama, Japan.
Br J Haematol. 2002 Dec;119(3):616-21. doi: 10.1046/j.1365-2141.2002.03866.x.
As a wide range of disorders underlie haemophagocytic syndrome, a rapid distinction between benign polyclonal and malignant monoclonal lymphoid proliferations is critical. We investigated whether polymerase chain reaction (PCR) amplification of immunoglobulin heavy chain gene rearrangement could efficiently detect clonal B-cell populations in non-diagnostic marrow for B-cell lymphoma-associated haemophagocytic syndrome (B-LAHS). On amplifying two DNA samples per biopsy, no reproducible monoclonal PCR result was found in reactive haemophagocytic marrows. In contrast, four out of nine assessable B-LAHS patients with histomorphologically and immunohistochemically lymphoma-free bone marrow showed a reproducible monoclonal immunoglobulin heavy chain gene rearrangement. At the molecular level, two B-LAHS patients had lymphoma-free marrow as demonstrated by patient-specific PCR, suggesting that haemophagocytic marrow is not always associated with lymphoma involvement. PCR-based demonstration of clonal B-cell populations in marrow would add an extra dimension to B-LAHS diagnosis.
由于噬血细胞综合征存在多种潜在病症,因此快速区分良性多克隆和恶性单克隆淋巴细胞增殖至关重要。我们研究了免疫球蛋白重链基因重排的聚合酶链反应(PCR)扩增能否有效检测与B细胞淋巴瘤相关噬血细胞综合征(B-LAHS)的非诊断性骨髓中的克隆性B细胞群体。在每份活检样本中扩增两个DNA样本时,在反应性噬血细胞骨髓中未发现可重复的单克隆PCR结果。相比之下,在9例可评估的B-LAHS患者中,有4例组织形态学和免疫组织化学检查显示骨髓无淋巴瘤,但却出现了可重复的单克隆免疫球蛋白重链基因重排。在分子水平上,通过患者特异性PCR证明,2例B-LAHS患者的骨髓无淋巴瘤,这表明噬血细胞骨髓并不总是与淋巴瘤累及相关。基于PCR证明骨髓中存在克隆性B细胞群体将为B-LAHS的诊断增添新的维度。